Skip to main content
. 2023 Jul 15;8(4):1030–1040. doi: 10.1177/23969873231186863

Table 3.

Characteristics of the patients having or not combined outcome event.

Combined outcome event
N = 64
No outcome event
N = 539
p
Age (mean, years) 72.4 ± 11.6 69.2 ± 12.7 0.05
NIHSS on admission (mean) 13.3 ± 7.1 7.9 ± 6.8 <0.0001
Sex male 39 (60.9%) 297 (55.1%) 0.4
Diabetes Mellitus 20 (31.2%) 122 (22.6%) 0.2
Hypertension 49 (76.6%) 380 (70.5%) 0.3
Hyperlipidemia 27 (42.2%) 254 (47.1%) 0.5
Atrial fibrillation 38 (59.4%) 278 (51.6%) 0.3
History of stroke 30 (46.9%) 165 (30.6%) 0.01
Smoking (ongoing) 16 (25.0%) 95 (17.6%) 0.2
Alcoholism 8 (12.5%) 55 (10.2%) 0.5
Congestive heart failure 19 (29.7%) 108 (20.0%) 0.1
History of myocardial infarction 16 (25.0%) 92 (17.1%) 0.1
Peripheral artery disease 11 (17.2%) 51 (9.5%) 0.07
Pacemaker 14 (21.9%) 66 (12.2%) 0.04
Lesion size <0.0001
 Small 12 (18.8%) 266 (49.4%)
 Medium 24 (37.5%) 168 (31.1%)
 Large 28 (43.7%) 105 (19.5%)
Leukoaraiosis 38 (59.4%) 283 (52.5%) 0.3
Intracardiac thrombus 6 (9.4%) 30 (5.6%) 0.2
rtPA 10 (15.6%) 62 (11.5%) 0.3
rtPA and/or mechanical thrombectomy 20 (31.2%) 135 (25.0%) 0.3
INR⩾2.5 18 (28.1%) 133 (24.7%) 0.3
Timing of anticoagulant therapy initiation (mean, days) 5.6 ± 14.5 3.2 ± 3.9 0.003